SCRIB and breast cancer: We have previously demonstrated that SCRIB was frequently mislocalized in triple-negative breast cancers (TNBC) and that expression of a membrane localization defective SCRIB mutant (P305L) activates the Akt pathway to promote cell proliferation in breast cancer cells9.